CDKN2A and melanoma: It should also be put into consideration that various molecular changes underlie the initiation and progression of melanoma, including the mutations in BRAF and NRAS genes [22], hyperactivation of the PI3K/AKT pathway [23], inactivation of p53 [24] and alterations in the CDK4/CDKN2A axis [25].